Cancer detection using Artificial Intelligence (AI) involves leveraging advanced machine learning algorithms and techniques to identify and diagnose cancer from various medical data sources. The goal is to enhance early detection, improve diagnostic accuracy, and potentially reduce the need for invasive procedures.
Data scarcity hinders deep learning for medical imaging. We propose a framework for breast cancer classification in thermograms that addresses this using a Diffusion Probabilistic Model (DPM) for data augmentation. Our DPM-based augmentation is shown to be superior to both traditional methods and a ProGAN baseline. The framework fuses deep features from a pre-trained ResNet-50 with handcrafted nonlinear features (e.g., Fractal Dimension) derived from U-Net segmented tumors. An XGBoost classifier trained on these fused features achieves 98.0\% accuracy and 98.1\% sensitivity. Ablation studies and statistical tests confirm that both the DPM augmentation and the nonlinear feature fusion are critical, statistically significant components of this success. This work validates the synergy between advanced generative models and interpretable features for creating highly accurate medical diagnostic tools.



Breast cancer remains a leading cause of cancer-related mortality among women worldwide. Ultrasound imaging, widely used due to its safety and cost-effectiveness, plays a key role in early detection, especially in patients with dense breast tissue. This paper presents a comprehensive study on the application of machine learning and deep learning techniques for breast cancer classification using ultrasound images. Using datasets such as BUSI, BUS-BRA, and BrEaST-Lesions USG, we evaluate classical machine learning models (SVM, KNN) and deep convolutional neural networks (ResNet-18, EfficientNet-B0, GoogLeNet). Experimental results show that ResNet-18 achieves the highest accuracy (99.7%) and perfect sensitivity for malignant lesions. Classical ML models, though outperformed by CNNs, achieve competitive performance when enhanced with deep feature extraction. Grad-CAM visualizations further improve model transparency by highlighting diagnostically relevant image regions. These findings support the integration of AI-based diagnostic tools into clinical workflows and demonstrate the feasibility of deploying high-performing, interpretable systems for ultrasound-based breast cancer detection.




Micro-ultrasound (micro-US) is a promising imaging technique for cancer detection and computer-assisted visualization. This study investigates prostate capsule segmentation using deep learning techniques from micro-US images, addressing the challenges posed by the ambiguous boundaries of the prostate capsule. Existing methods often struggle in such cases, motivating the development of a tailored approach. This study introduces an adaptive focal loss function that dynamically emphasizes both hard and easy regions, taking into account their respective difficulty levels and annotation variability. The proposed methodology has two primary strategies: integrating a standard focal loss function as a baseline to design an adaptive focal loss function for proper prostate capsule segmentation. The focal loss baseline provides a robust foundation, incorporating class balancing and focusing on examples that are difficult to classify. The adaptive focal loss offers additional flexibility, addressing the fuzzy region of the prostate capsule and annotation variability by dilating the hard regions identified through discrepancies between expert and non-expert annotations. The proposed method dynamically adjusts the segmentation model's weights better to identify the fuzzy regions of the prostate capsule. The proposed adaptive focal loss function demonstrates superior performance, achieving a mean dice coefficient (DSC) of 0.940 and a mean Hausdorff distance (HD) of 1.949 mm in the testing dataset. These results highlight the effectiveness of integrating advanced loss functions and adaptive techniques into deep learning models. This enhances the accuracy of prostate capsule segmentation in micro-US images, offering the potential to improve clinical decision-making in prostate cancer diagnosis and treatment planning.
Spatial transcriptomics is an emerging field that enables the identification of functional regions based on the spatial distribution of gene expression. Integrating this functional information present in transcriptomic data with structural data from histopathology images is an active research area with applications in identifying tumor substructures associated with cancer drug resistance. Current histopathology-spatial-transcriptomic region segmentation methods suffer due to either making spatial transcriptomics prominent by using histopathology features just to assist processing spatial transcriptomics data or using vanilla contrastive learning that make histopathology images prominent due to only promoting common features losing functional information. In both extremes, the model gets either lost in the noise of spatial transcriptomics or overly smoothed, losing essential information. Thus, we propose our novel architecture SENCA-st (Shared Encoder with Neighborhood Cross Attention) that preserves the features of both modalities. More importantly, it emphasizes regions that are structurally similar in histopathology but functionally different on spatial transcriptomics using cross-attention. We demonstrate the superior performance of our model that surpasses state-of-the-art methods in detecting tumor heterogeneity and tumor micro-environment regions, a clinically crucial aspect.




Cervical cancer remains a significant global health concern and a leading cause of cancer-related deaths among women. Early detection through Pap smear tests is essential to reduce mortality rates; however, the manual examination is time consuming and prone to human error. This study proposes a deep learning framework that integrates U-Net for segmentation and a classification model to enhance diagnostic performance. The Herlev Pap Smear Dataset, a publicly available cervical cell dataset, was utilized for training and evaluation. The impact of segmentation on classification performance was evaluated by comparing the model trained on segmented images and another trained on non-segmented images. Experimental results showed that the use of segmented images marginally improved the model performance on precision (about 0.41 percent higher) and F1-score (about 1.30 percent higher), which suggests a slightly more balanced classification performance. While segmentation helps in feature extraction, the results showed that its impact on classification performance appears to be limited. The proposed framework offers a supplemental tool for clinical applications, which may aid pathologists in early diagnosis.
Pacreatic ductal adenocarcinoma (PDAC) remains one of the most lethal forms of cancer, with a five-year survival rate below 10% primarily due to late detection. This research develops and validates a deep learning framework for early PDAC detection through analysis of dual-modality imaging: autofluorescence and second harmonic generation (SHG). We analyzed 40 unique patient samples to create a specialized neural network capable of distinguishing between normal, fibrotic, and cancerous tissue. Our methodology evaluated six distinct deep learning architectures, comparing traditional Convolutional Neural Networks (CNNs) with modern Vision Transformers (ViTs). Through systematic experimentation, we identified and overcome significant challenges in medical image analysis, including limited dataset size and class imbalance. The final optimized framework, based on a modified ResNet architecture with frozen pre-trained layers and class-weighted training, achieved over 90% accuracy in cancer detection. This represents a significant improvement over current manual analysis methods an demonstrates potential for clinical deployment. This work establishes a robust pipeline for automated PDAC detection that can augment pathologists' capabilities while providing a foundation for future expansion to other cancer types. The developed methodology also offers valuable insights for applying deep learning to limited-size medical imaging datasets, a common challenge in clinical applications.
Lung cancer (LC) ranks among the most frequently diagnosed cancers and is one of the most common causes of death for men and women worldwide. Computed Tomography (CT) images are the most preferred diagnosis method because of their low cost and their faster processing times. Many researchers have proposed various ways of identifying lung cancer using CT images. However, such techniques suffer from significant false positives, leading to low accuracy. The fundamental reason results from employing a small and imbalanced dataset. This paper introduces an innovative approach for LC detection and classification from CT images based on the DenseNet201 model. Our approach comprises several advanced methods such as Focal Loss, data augmentation, and regularization to overcome the imbalanced data issue and overfitting challenge. The findings show the appropriateness of the proposal, attaining a promising performance of 98.95% accuracy.
Early detection of lung cancer is critical to improving survival outcomes. We present a deep learning framework for automated lung cancer screening from chest computed tomography (CT) images with integrated explainability. Using the IQ-OTH/NCCD dataset (1,197 scans across Normal, Benign, and Malignant classes), we evaluate a custom convolutional neural network (CNN) and three fine-tuned transfer learning backbones: DenseNet121, ResNet152, and VGG19. Models are trained with cost-sensitive learning to mitigate class imbalance and evaluated via accuracy, precision, recall, F1-score, and ROC-AUC. While ResNet152 achieved the highest accuracy (97.3%), DenseNet121 provided the best overall balance in precision, recall, and F1 (up to 92%, 90%, 91%, respectively). We further apply Shapley Additive Explanations (SHAP) to visualize evidence contributing to predictions, improving clinical transparency. Results indicate that CNN-based approaches augmented with explainability can provide fast, accurate, and interpretable support for lung cancer screening, particularly in resource-limited settings.




Accurate detection and segmentation of cancerous lesions from computed tomography (CT) scans is essential for automated treatment planning and cancer treatment response assessment. Transformer-based models with self-supervised pretraining can produce reliably accurate segmentation from in-distribution (ID) data but degrade when applied to out-of-distribution (OOD) datasets. We address this challenge with RF-Deep, a random forest classifier that utilizes deep features from a pretrained transformer encoder of the segmentation model to detect OOD scans and enhance segmentation reliability. The segmentation model comprises a Swin Transformer encoder, pretrained with masked image modeling (SimMIM) on 10,432 unlabeled 3D CT scans covering cancerous and non-cancerous conditions, with a convolution decoder, trained to segment lung cancers in 317 3D scans. Independent testing was performed on 603 3D CT public datasets that included one ID dataset and four OOD datasets comprising chest CTs with pulmonary embolism (PE) and COVID-19, and abdominal CTs with kidney cancers and healthy volunteers. RF-Deep detected OOD cases with a FPR95 of 18.26%, 27.66%, and less than 0.1% on PE, COVID-19, and abdominal CTs, consistently outperforming established OOD approaches. The RF-Deep classifier provides a simple and effective approach to enhance reliability of cancer segmentation in ID and OOD scenarios.




Breast cancer detection through mammography interpretation remains difficult because of the minimal nature of abnormalities that experts need to identify alongside the variable interpretations between readers. The potential of CNNs for medical image analysis faces two limitations: they fail to process both local information and wide contextual data adequately, and do not provide explainable AI (XAI) operations that doctors need to accept them in clinics. The researcher developed the MammoFormer framework, which unites transformer-based architecture with multi-feature enhancement components and XAI functionalities within one framework. Seven different architectures consisting of CNNs, Vision Transformer, Swin Transformer, and ConvNext were tested alongside four enhancement techniques, including original images, negative transformation, adaptive histogram equalization, and histogram of oriented gradients. The MammoFormer framework addresses critical clinical adoption barriers of AI mammography systems through: (1) systematic optimization of transformer architectures via architecture-specific feature enhancement, achieving up to 13% performance improvement, (2) comprehensive explainable AI integration providing multi-perspective diagnostic interpretability, and (3) a clinically deployable ensemble system combining CNN reliability with transformer global context modeling. The combination of transformer models with suitable feature enhancements enables them to achieve equal or better results than CNN approaches. ViT achieves 98.3% accuracy alongside AHE while Swin Transformer gains a 13.0% advantage through HOG enhancements